Assessing the impact of drug resistance and treatment on malaria transmission dynamics

被引:0
作者
Akindele Akano Onifade
Mayowa Michael Ojo
机构
[1] Mountain Top University,Department of Computer Science and Mathematics
[2] University of South Africa,Department of Mathematics
来源
Modeling Earth Systems and Environment | 2024年 / 10卷
关键词
Malaria; Mathematical model; Drug resistance; Antimalarial; Reproduction number; Stability;
D O I
暂无
中图分类号
学科分类号
摘要
Malaria is an ancient parasitic disease of humans caused by a protozoan of the genus Plasmodium and it is transmitted by infected female Anopheles mosquitoes. The model incorporates optimal sequencing (i.e., optimal sequencing of available antimalarial drugs from different classes to achieve the most effective treatment in malaria-endemic regions) and treatment (appropriate proportion of the exposed population that should receive treatment to restrict antimalarial resistance). Optimal sequencing, appropriate use of antimalarial in reducing wide spread of drug resistance, proper preventive measures, and timely medical care are essential in managing and controlling malaria. First, we analyze the state of malaria infection, calculate the baseline reproduction number, and study the local stability of malaria-free equilibrium. Numerical simulations of the malaria model is conducted using MATLAB program to investigate the dynamics of malaria under different scenarios (what if scenarios). The result of our simulations reveal that to effectively control widespread drugs resistance, it is crucial for policymakers to ensure that individuals who become resistant to a particular treatment must be introduced to another form of treatment to confer recovery from infection. This should also be complemented with the WHO-recommended non-pharmaceutical preventive measures.
引用
收藏
页码:2905 / 2916
页数:11
相关论文
共 148 条
  • [1] Alker AP(2007)PFMDR1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border Am J Trop Med Hyg 76 641-647
  • [2] Lim P(2014)A molecular marker of artemisinin-resistant Plasmodium falciparum malaria Nature. 505 50-55
  • [3] Sem R(2010)Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technology Malar J 9 270-395
  • [4] Shah NK(2006)Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change Am J Trop Med Hyg 75 388-1590
  • [5] Yi P(1999)Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines J Infect Dis 179 1587-124
  • [6] Ariey F(1999)Chemotherapy of malaria and resistance to antimalarial drugs in Guayana area Venezuela. Am. J. Trop. Med. Hyg. 61 120-29
  • [7] Witkowski B(2009)Effects of treatment and drug resistance on the transmission dynamics of malaria in endemic areas Theor Popul Biol 75 14-741
  • [8] Amaratunga C(2022)A mathematical model for the dynamics and control of malaria in Nigeria Infect Dis Model 7 728-4443
  • [9] Beghain J(2006)Elucidation of sulfadoxine resistance with structural models of the bifunctional Plasmodium falciparum dihydropterin pyrophosphokinase-dihydropteroate synthase Bioorg Med Chem 14 4433-52
  • [10] Langlois AC(2010)Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates Malar J 9 68-630